A drug-resistant fungus, Candida auris, is spreading rapidly through American hospitals, with clinical infections more than doubling between 2022 and 2024. While the overall case count has surged, the increase in bloodstream infections, a more definitive indicator of invasive disease, was approximately 60%. The rise in cases may be attributed to both increased transmission and enhanced surveillance efforts, including expanded screening at hospital admissions. A key concern is the fungus's resistance to antifungal drugs, though susceptibility data is not yet captured in current surveillance. AI
RANK_REASON Public health report on a spreading infectious disease. [lever_c_demoted from significant: ic=1 ai=0.0]
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
